A Pilot Study of Buspirone for the Treatment of Anxiety in Youth with Autism Spectrum Disorders

Summary

The main objective of this exploratory 8-week pilot study is to evaluate the safety and efficacy of buspirone for the treatment of anxiety in youth (ages 6-17 years) with autism spectrum disorders. The study results will be used to generate hypotheses for a larger randomized-controlled trial with explicit hypotheses and sufficient statistical power.

Timeline

Start

2024-12

Primary completion

2025-08

Completion

2025-08

Drugs

Indications